← The FDA Ephemeris: the whole map
Rexulti brexpiprazole
Listed: the approval is known from Drugs@FDA; its review documents are not yet in the Ephemeris.
- Application
- NDA 205422
- Sponsor
- Otsuka
- Drug class
- Atypical antipsychotic
- First approved
- July 10, 2015
- Drugs@FDA status
- Prescription
NDA 205422 on Drugs@FDA
From FDA documents. Not medical advice.